Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 4
2010 4
2011 3
2012 4
2013 6
2014 3
2015 6
2016 3
2017 8
2018 7
2019 7
2020 2
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Results by year
Filters applied: . Clear all
Page 1
Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models.
Wu L, Vasilijic S, Sun Y, Chen J, Landegger LD, Zhang Y, Zhou W, Ren J, Early S, Yin Z, Ho WW, Zhang N, Gao X, Lee GY, Datta M, Sagers JE, Brown A, Muzikansky A, Stemmer-Rachamimov A, Zhang L, Plotkin SR, Jain RK, Stankovic KM, Xu L. Wu L, et al. Sci Transl Med. 2021 Jul 14;13(602):eabd4816. doi: 10.1126/scitranslmed.abd4816. Sci Transl Med. 2021. PMID: 34261799 Free PMC article.
Antiangiogenic therapy for glioblastoma.
Gerstner ER, Batchelor TT. Gerstner ER, et al. Cancer J. 2012 Jan-Feb;18(1):45-50. doi: 10.1097/PPO.0b013e3182431c6f. Cancer J. 2012. PMID: 22290257 Free PMC article. Review.
Primary Central Nervous System Lymphoma.
Han CH, Batchelor TT. Han CH, et al. Continuum (Minneap Minn). 2017 Dec;23(6, Neuro-oncology):1601-1618. doi: 10.1212/CON.0000000000000539. Continuum (Minneap Minn). 2017. PMID: 29200113 Review.
50 results